Is PSTI or HDV a better dividend investment in 2026?

PSTI currently yields 200.00% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: PSTI offers higher current income.

What is the dividend yield difference between PSTI and HDV?

PSTI has a forward dividend yield of 200.00% ($2.00/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 197.08 percentage points.

Home › Compare › PSTI vs HDV

PSTI vs HDV: Dividend Comparison 2026

PSTI yields 200.00% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PSTI wins by $119.34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PSTI

● Live price

200.00%

Share price

$1.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$119.36M

Annual income

$60,176,096.29

Full PSTI calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.39

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$352.73

Full HDV calculator →

Portfolio growth — PSTI vs HDV

📍 PSTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PSTI	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PSTI + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PSTI pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PSTI

Annual income on $10K today (after 15% tax)

$17,000.00/yr

After 10yr DRIP, annual income (after tax)

$51,149,681.85/yr

HDV

Annual income on $10K today (after 15% tax)

$248.52/yr

After 10yr DRIP, annual income (after tax)

$299.82/yr

At 15% tax rate, PSTI beats the other by $51,149,382.03/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PSTI + HDV for your $10,000?

PSTI: 50%HDV: 50%

100% HDV50/50100% PSTI

Portfolio after 10yr

$59.69M

Annual income

$30,088,224.50/yr

Blended yield

50.40%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PSTI right now

PSTI

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-41.5

Piotroski

4/9

HDV

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PSTI buys

HDV buys

No recent congressional trades found for PSTI or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPSTIHDV

Forward yield	200.00% ✓	2.92%
Annual dividend / share	$2.00	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$119.36M ✓	$24.3K
Annual income after 10y	$60,176,096.29 ✓	$352.73
Total dividends collected	$112.49M ✓	$3.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PSTI vs HDV ($10,000, DRIP)

Year	PSTI Portfolio	PSTI Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$30,700	$20,000.00	$11,002	$292.38	+$19.7K → PSTI
2	$90,232	$57,383.18	$12,084	$300.36	+$78.1K → PSTI
3	$254,173	$157,624.56	$13,250	$308.02	+$240.9K → PSTI
4	$686,927	$414,961.74	$14,506	$315.35	+$672.4K → PSTI
5	$1,783,118	$1,048,106.39	$15,858	$322.35	+$1.77M → PSTI
6	$4,450,613	$2,542,677.12	$17,313	$329.04	+$4.43M → PSTI
7	$10,693,420	$5,931,263.38	$18,878	$335.42	+$10.67M → PSTI
8	$24,760,608	$13,318,648.86	$20,560	$341.49	+$24.74M → PSTI
9	$55,315,649	$28,821,798.66	$22,367	$347.25	+$55.29M → PSTI
10	$119,363,841	$60,176,096.29	$24,307	$352.73	+$119.34M → PSTI

PSTI vs HDV: Complete Analysis 2026

PSTI — Stock

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.

Full PSTI Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this PSTI vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PSTI vs SCHD PSTI vs JEPI PSTI vs O PSTI vs KO PSTI vs MAIN PSTI vs VYM PSTI vs DVY PSTI vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.